Verona Pharma Plc ADR
(VRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | HALO | ARWR | ||
| Company | Verona Pharma Plc ADR | Halozyme Therapeutic | Arrowhead Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 106.85 | 77.83 | 61.13 | ||
| High | 106.93 | 81.19 | 64.48 | ||
| Low | 106.81 | 77.55 | 60.90 | ||
| Latest | 106.91 | 79.44 | 63.82 | ||
| Change | +0.12 | +2.52 | +1.44 | ||
| % Change | +0.11% | +3.28% | +2.31% | ||
| Volume | 1,871,900 | 1,735,800 | 1,990,700 | ||
| 20-Day Average Volume | 1,504,320 | 1,835,355 | 3,524,385 | ||
| Previous Close | 106.79 | 76.92 | 62.38 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 106.48 | 74.85 | 66.34 | ||
| 20-Day Raw Stochastic | 98.26% | 79.21% | 22.07% | ||
| 20-Day Relative Strength | 70.52 | 61.93 | 49.19 | ||
| Weighted Alpha | +201.62 | +43.65 | +212.92 | ||
| Today's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 09/29/25 | -2.20% since 02/06/26 | -1.08% since 02/06/26 | ||
| Low | 106.61 on 09/30/25 | 76.10 on 02/12/26 | 60.34 on 02/11/26 | ||
| High | 106.93 on 10/06/25 | 82.22 on 02/09/26 | 65.09 on 02/09/26 | ||
| 1-Month | |||||
| %Chg | +0.56% since 09/05/25 | +10.84% since 01/13/26 | -2.63% since 01/13/26 | ||
| Low | 105.78 on 09/19/25 | 68.85 on 01/26/26 | 60.34 on 02/11/26 | ||
| High | 106.93 on 10/06/25 | 82.22 on 02/09/26 | 76.11 on 02/03/26 | ||
| 3-Month | |||||
| %Chg | +16.80% since 07/03/25 | +11.59% since 11/13/25 | +55.13% since 11/13/25 | ||
| Low | 86.63 on 07/08/25 | 61.22 on 12/11/25 | 37.06 on 11/20/25 | ||
| High | 106.93 on 10/06/25 | 82.22 on 02/09/26 | 76.76 on 01/06/26 | ||
| 6-Month | |||||
| %Chg | +98.35% since 04/04/25 | +21.97% since 08/13/25 | +219.26% since 08/13/25 | ||
| Low | 47.20 on 04/07/25 | 61.22 on 12/11/25 | 18.14 on 08/14/25 | ||
| High | 106.93 on 10/06/25 | 82.22 on 02/09/26 | 76.76 on 01/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,748,446 | 9,045,561 | 8,735,195 | ||
| Shares Outstanding, K | 81,830 | 117,597 | 140,032 | ||
| Annual Sales | 42,280,000 | 1,015,320,000 | 829,450,000 | ||
| Annual Net Income | -173,420,000 | 444,090,000 | -1,630,000 | ||
| Last Quarter Sales | 103,140,000 | 354,260,000 | 264,030,000 | ||
| Last Quarter Net Income | 11,920,000 | 175,230,000 | 30,810,000 | ||
| 60-Month Beta | 0.05 | 0.97 | 1.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/06/25 | 1.72 on 11/03/25 | 0.22 on 02/05/26 | ||
| Latest Earnings Date | 11/03/25 | 02/17/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.95 | 40.23 | ||